Nizar M Tannir (N Tannir, N M Tannir)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 30

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

The oncologist

Cancer discovery

Proceedings of the National Academy of Sciences of the United States of America

University of Texas MD Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas MD Anderson Cancer Center

United States

Professor and Deputy Chair :: Genitourinary Medical Oncology

Publications

Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary A Tagliaferri, Daniel J George, Archana M Agarwal, Sumanta Kumar Pal
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Matthew T Campbell, Amishi Yogesh Shah, Pavlos Msaouel, Nizar M Tannir, Arlene O Siefker-Radtke, Ashish M Kamat, Neema Navai, Colin P N Dinney, Priya Rao, Charles C Guo, Rahul A Sheth, Aradhana M Venkatesan, Rebecca S Slack Tidwell, Shalini Singh Yadav, Aidi Gu, Hong Chen, Marc Macaluso, Fei Duan, Sreyashi Basu, Sonali Jindal, Padmanee Sharma
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle Invasive Bladder Cancer. Cancer research communications (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist 29 (7) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist 29 (7) (2024)
Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary A Tagliaferri, Daniel J George, Archana M Agarwal, Sumanta Kumar Pal
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sumanta Kumar Pal, Ben Tran, John B A G Haanen, Michael E Hurwitz, Adrian Sacher, Nizar M Tannir, L Elizabeth Elizabeth Budde, Simon James Harrison, Sebastian Klobuch, Sagar S Patel, Luis Meza, Mary-Lee Dequeant, Anna Ma, Qiuling Ally He, Leah M Williams, Alissa Keegan, Ellen B Gurary, Henia Dar, Sushant Karnik, Changan Guo, Heidi Heath, Rachel R Yuen, Phuong K Morrow, Archana M Agarwal, Samer A Srour
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma. Cancer discovery 14 (7) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Andrew C Johns, Matthew T Campbell, Mamie Gao, Andrew W Hahn, Zita Lim, Emily Wang, Jianjun Gao, Amishi Y Shah, Pavlos Msaouel, Nizar M Tannir
Efficacy, Safety, and Tolerability of Tivozanib in Heavily Pretreated Patients With Advanced Clear Cell Renal Cell Carcinoma. The oncologist 29 (7) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Nizar M Tannir, Maria Nirvana Formiga, Konstantin Penkov, Nikolay Kislov, Aleksandr Vasiliev, Nils Gunnar Skare, Walter Hong, Stanley Dai, Lily Tang, Anila Qureshi, Jonathan Zalevsky, Mary A Tagliaferri, Daniel J George, Archana M Agarwal, Sumanta Kumar Pal
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (23) (2024)
James Brugarolas, Gregory Obara, Kathryn E Beckermann, Brian I Rini, Elaine T Lam, James Hamilton, Thomas Schluep, Min Yi, So C Wong, Zhongping Lily Mao, Erick Gamelin, Nizar M Tannir
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Melinda Soeung, Luigi Perelli, Ziheng Chen, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Li Zhang, Hania Khan, Courtney N Le, Cihui Zhu, Michael D Peoples, Ningping Feng, Shan Jiang, Niki Millward Zacharias, Rosalba Minelli, Daniel D Shapiro, Angela K Deem, Sisi Gao, Emily H Cheng, Donatella Lucchetti, Cheryl L Walker, Alessandro Carugo, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Nizar M Tannir, Giulio F Draetta, Pavlos Msaouel, Giannicola Genovese
SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Melinda Soeung, Luigi Perelli, Ziheng Chen, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Li Zhang, Hania Khan, Courtney N Le, Cihui Zhu, Michael D Peoples, Ningping Feng, Shan Jiang, Niki Millward Zacharias, Rosalba Minelli, Daniel D Shapiro, Angela K Deem, Sisi Gao, Emily H Cheng, Donatella Lucchetti, Cheryl L Walker, Alessandro Carugo, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Nizar M Tannir, Giulio F Draetta, Pavlos Msaouel, Giannicola Genovese
SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Arika S Feils, Amy K Erbe, Jennifer Birstler, KyungMann Kim, U Hoch, S L Currie, T Nguyen, D Yu, Arlene O Siefker-Radtke, Nizar M Tannir, Sara M Tolaney, Adi Diab, Paul M Sondel
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. Cancer immunology, immunotherapy : CII (2023)
Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail, Xuesong Zhang, Truong Nguyen Anh Lam, Anh Hoang, Elshad Hasanov, Ganiraju C Manyam, Christine B Peterson, Haifeng Zhu, Shwetha V Kumar, Rehan Akbani, Patrick G Pilié, Nizar M Tannir, Guang Peng, Eric Jonasch
SETD2 loss and ATR inhibition synergize to promote cGAS signaling and immunotherapy response in renal cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Melinda Soeung, Luigi Perelli, Ziheng Chen, Eleonora Dondossola, I-Lin Ho, Federica Carbone, Li Zhang, Hania Khan, Courtney N Le, Cihui Zhu, Michael D Peoples, Ningping Feng, Shan Jiang, Niki Millward Zacharias, Rosalba Minelli, Daniel D Shapiro, Angela K Deem, Sisi Gao, Emily H Cheng, Donatella Lucchetti, Cheryl L Walker, Alessandro Carugo, Virginia Giuliani, Timothy P Heffernan, Andrea Viale, Nizar M Tannir, Giulio F Draetta, Pavlos Msaouel, Giannicola Genovese
SMARCB1 regulates the hypoxic stress response in sickle cell trait. Proceedings of the National Academy of Sciences of the United States of America 120 (21) (2023)
Xiaofan Lu, Nassim Tawanaie Pour Sedehi, Xiaoping Su, Fangrong Yan, Omar Alhalabi, Nizar M Tannir, Gabriel G Malouf
Racial Disparities in MiT Family Translocation Renal Cell Carcinoma. The oncologist (2023)
Andrew W Hahn, Devaki Shilpa Surasi, Paul V Viscuse, Tharakeswara K Bathala, Andrew J Wiele, Matthew T Campbell, Amado J Zurita, Amishi Y Shah, Eric Jonasch, Jianjun Gao, Sangeeta Goswami, Omar Alhalabi, Priya Rao, Kanishka Sircar, Nizar M Tannir, Pavlos Msaouel
Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. The oncologist (2023)
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, Xuemei Wang, Ying Yuan, Eric Jonasch, Jianjun Gao, Matthew T Campbell, Amishi Yogesh Shah, Paul Gettys Corn, Alda L Tam, Kamran Ahrar, Priya Rao, Kanishka Sircar, Lorenzo Cohen, Sreyashi Basu, Fei Duan, Sonali Jindal, Yuwei Zhang, Hong Chen, Shalini Singh Yadav, Ronald Shazer, Hirak Der-Torossian, James P Allison, Padmanee Sharma, Nizar M Tannir
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Science translational medicine 14 (641) (2022)
Nizar M Tannir, Kyriakos P Papadopoulos, Deborah J Wong, Raid Aljumaily, Annie Hung, Manuel Afable, Jong Seok Kim, David Ferry, Alexandra Drakaki, Johanna Bendell, Aung Naing
Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study. International journal of cancer 149 (2) (2021)
Andrew J Wiele, Tharakeswara K Bathala, Andrew W Hahn, Lianchun Xiao, Munevver Duran, Jeremy A Ross, Eric Jonasch, Amishi Yogesh Shah, Matthew T Campbell, Pavlos Msaouel, Nizar M Tannir
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies. The oncologist 26 (6) (2021)
Omar Alhalabi, Elshad Hasanov, Nathaniel R Wilson, John Araujo, Jianbo Wang, Matthew T Campbell, Sangeeta Goswami, Amishi Y Shah, Jianjun Gao, Pavlos Msaouel, Nizar M Tannir
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience. International journal of cancer 149 (2) (2021)
Mary E Westerman, Daniel D Shapiro, Nizar M Tannir, Matthew T Campbell, Surena F Matin, Jose Antonio Karam, Christopher G Wood
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models. BJU international 126 (6) (2020)
Behrang Amini, Charles B Beaman, John E Madewell, P K Allen, Laurence D Rhines, Claudio Esteves Tatsui, Nizar M Tannir, J Li, P D Brown, Amol J Ghia
Osseous Pseudoprogression in Vertebral Bodies Treated with Stereotactic Radiosurgery: A Secondary Analysis of Prospective Phase I/II Clinical Trials. AJNR. American journal of neuroradiology 37 (2) (2015)

Nizar M Tannir.css-eqlu8i{font-size:small;padding-left:4px;} (N Tannir, N M Tannir)

Publication Activity (10 Years)

Top Topics

Top Venues

Nizar M Tannir (N Tannir, N M Tannir)